If you experience increased blood levels of AST and ALT, and these levels return to normal within 7 days of completing the treatment cycle, you may be eligible to continue atiprimod treatment, but at a lower dose level and on a modified schedule. If you do receive a modified schedule of atiprimod, you will return to the clinic for an additional evaluation on Week 2 (Day 14) of the modified cycle (in addition to the evaluation that you will have at the end of the cycle). This evaluation will include the same tests done at the monthly visits, except that your tumor will not be measured and you will not have a pregnancy test.